These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 37856537)
1. Cross-feeding affects the target of resistance evolution to an antifungal drug. Durand R; Jalbert-Ross J; Fijarczyk A; Dubé AK; Landry CR PLoS Genet; 2023 Oct; 19(10):e1011002. PubMed ID: 37856537 [TBL] [Abstract][Full Text] [Related]
2. Mutational analysis of flucytosine resistance in Candida glabrata. Edlind TD; Katiyar SK Antimicrob Agents Chemother; 2010 Nov; 54(11):4733-8. PubMed ID: 20823283 [TBL] [Abstract][Full Text] [Related]
3. Molecular mechanism of flucytosine resistance in Candida lusitaniae: contribution of the FCY2, FCY1, and FUR1 genes to 5-fluorouracil and fluconazole cross-resistance. Papon N; Noël T; Florent M; Gibot-Leclerc S; Jean D; Chastin C; Villard J; Chapeland-Leclerc F Antimicrob Agents Chemother; 2007 Jan; 51(1):369-71. PubMed ID: 17060521 [TBL] [Abstract][Full Text] [Related]
4. Genetic prerequisites for additive or synergistic actions of 5-fluorocytosine and fluconazole in baker's yeast. Paluszynski JP; Klassen R; Meinhardt F Microbiology (Reading); 2008 Oct; 154(Pt 10):3154-3164. PubMed ID: 18832321 [TBL] [Abstract][Full Text] [Related]
5. Various cytosine/adenine permease homologues are involved in the toxicity of 5-fluorocytosine in Saccharomyces cerevisiae. Paluszynski JP; Klassen R; Rohe M; Meinhardt F Yeast; 2006 Jul; 23(9):707-15. PubMed ID: 16845689 [TBL] [Abstract][Full Text] [Related]
6. Resistance in human pathogenic yeasts and filamentous fungi: prevalence, underlying molecular mechanisms and link to the use of antifungals in humans and the environment. Jensen RH Dan Med J; 2016 Oct; 63(10):. PubMed ID: 27697142 [TBL] [Abstract][Full Text] [Related]
7. Antifungal drug resistance in pathogenic fungi. Vanden Bossche H; Dromer F; Improvisi I; Lozano-Chiu M; Rex JH; Sanglard D Med Mycol; 1998; 36 Suppl 1():119-28. PubMed ID: 9988500 [TBL] [Abstract][Full Text] [Related]
15. Adaptation to Fluconazole via Aneuploidy Enables Cross-Adaptation to Amphotericin B and Flucytosine in Cryptococcus neoformans. Yang F; Gritsenko V; Lu H; Zhen C; Gao L; Berman J; Jiang YY Microbiol Spectr; 2021 Oct; 9(2):e0072321. PubMed ID: 34585947 [TBL] [Abstract][Full Text] [Related]
16. [Molecular and biochemical mechanisms of drug resistance in fungi]. Yamaguchi H Nihon Ishinkin Gakkai Zasshi; 1999; 40(4):199-208. PubMed ID: 10536306 [TBL] [Abstract][Full Text] [Related]
18. Genomic Diversity across Candida auris Clinical Isolates Shapes Rapid Development of Antifungal Resistance Burrack LS; Todd RT; Soisangwan N; Wiederhold NP; Selmecki A mBio; 2022 Aug; 13(4):e0084222. PubMed ID: 35862787 [TBL] [Abstract][Full Text] [Related]
19. Moderate levels of 5-fluorocytosine cause the emergence of high frequency resistance in cryptococci. Chang YC; Lamichhane AK; Cai H; Walter PJ; Bennett JE; Kwon-Chung KJ Nat Commun; 2021 Jun; 12(1):3418. PubMed ID: 34103502 [TBL] [Abstract][Full Text] [Related]
20. Triazole Evolution of Candida parapsilosis Results in Cross-Resistance to Other Antifungal Drugs, Influences Stress Responses, and Alters Virulence in an Antifungal Drug-Dependent Manner. Papp C; Bohner F; Kocsis K; Varga M; Szekeres A; Bodai L; Willis JR; Gabaldón T; Tóth R; Nosanchuk JD; Vágvölgyi C; Gácser A mSphere; 2020 Oct; 5(5):. PubMed ID: 33115837 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]